Inventor · disambiguated record
Mark Leslie Smythe
Also filed as: SMYTHE MARK · SMYTHE MARK L · SMYTHE MARK LESLIE
14 granted patents·18 pending applications·177 citations·filing 1999–2025
93Inventor score
Top patents by PatentIndex Score
32 records- 0196US11472842B2Analogues of hepcidin mimetics with improved in vivo half livesPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Oct 18, 2022·5 cites·11 claims
- 0296US10030061B2Hepcidin analogues and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Jul 24, 2018·29 cites·24 claims
- 0395US11807674B2Hepcidin analogues and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Nov 7, 2023·3 cites·4 claims
- 0495US10501515B2Hepcidin analogues and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2019·Granted Dec 10, 2019·18 cites·30 claims
- 0595US10442846B2Hepcidin analogues and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted Oct 15, 2019·19 cites·19 claims
- 0695US9822157B2Hepcidin analogues and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2014·Granted Nov 21, 2017·35 cites·9 claims
- 0787US12269856B2Hepcidin analogues and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·15 claims
- 0886US11753443B2Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2019·Granted Sep 12, 2023·3 cites·10 claims
- 0979US2025340608A1Hepcidin analogues and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1078US12234300B2Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2023·Granted Feb 25, 2025·0 cites·18 claims
- 1174US9199976B2Haematopoietic-prostaglandin D2 synthase inhibitorsSMYTHE MARK LESLIE·Filed 2011·Granted Dec 1, 2015·5 cites·11 claims
- 1273US7589170B1Synthesis of cyclic peptidesUNIV QUEENSLAND·Filed 1999·Granted Sep 15, 2009·40 cites·24 claims
- 1372US2025327065A1Disulfide-rich peptide libraries and methods of use thereofPROTAGONIST THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1470US2024066131A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1570US2024018189A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1668US2023295259A1Conjugated Hepcidin MimeticsPROTAGONIST THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1764US8635027B2Common protein surface shapes and uses thereforSMYTHE MARK LESLIE·Filed 2009·Granted Jan 21, 2014·0 cites·23 claims
- 1864US2025304624A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1964US2025361280A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2064US2018100004A1Hepcidin analogues and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2162US2025170216A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2261US7718598B1Auxiliary for amide bond formationUNIV QUEENSLAND·Filed 1999·Granted May 18, 2010·15 cites·33 claims
- 2360US2007016380A1Protein engineeringUNIV QUEENSLAND·Filed 2006·Application pending·0 cites
- 2460US2024226225A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2558US2005154533A1Common protein surface shapes and uses thereforUNIV QUEENSLAND·Filed 2003·Application pending·0 cites
- 2656US2025277012A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2753US2020017566A1Hepcidin and mini-hepcidin analogues and uses therofPROTAGONIST THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2851US2019002503A1Analogues of hepcidin mimetics with improved in vivo half livesPROTAGONIST THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2949US2019264197A1Disulfide-rich peptide libraries and methods of use thereofPROTAGONIST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3043US2016200814A1Immunoreceptor modulation for treating cancer and viral infectionsQUEENSLAND INST MED RES·Filed 2013·Application pending·0 cites
- 3142US2017313754A1Hepcidin and mini-hepcidin analogues and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3232US7092825B1Protein engineeringUNIV QUEENSLAND·Filed 1999·Granted Aug 15, 2006·5 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Mark Leslie Smythe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →